Press release
Carbapenem-Based Antibiotics Market Trends That Will Shape the Next Decade: Insights from Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market
Carbapenem-Based Antibiotics
How Large Will the Carbapenem-Based Antibiotics Market Size By 2025?
The market size of carbapenem-based antibiotics has been consistently expanding over the past few years. It is predicted that the market will increase from $4.6 billion in 2024 to $4.82 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.8%. The uptick in growth during the historical period can be tied to factors like epidemics and pandemics, the escalating number of chronic diseases, expansion of healthcare infrastructure, swift urbanization, natural disasters, and health emergencies.
How Big Is the Carbapenem-Based Antibiotics Market Size Expected to Grow by 2029?
Projected solid growth is expected in the carbapenem-based antibiotics market in the coming years. This market is expected to reach $6.09 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.0%. The predicted growth for this forecast period can be accredited to factors such as the heightened occurrence of infections acquired in hospitals, the surfacing of multi-drug resistant strains, an escalating elderly population, an increase in surgical procedures, the spread of infectious diseases, and changing demographics. Key trends anticipated for this forecast period encompass security and resilience of the supply chain, development of alternative treatment, a shift towards outpatient care, rising awareness about antimicrobial stewardship, and the use of precision medicine approaches.
View the full report here:
https://www.thebusinessresearchcompany.com/report/carbapenem-based-antibiotics-global-market-report
Which Key Market Drivers Powering Carbapenem-Based Antibiotics Market Expansion and Growth?
Growth in the carbapenem-based antibiotics market is projected to be spurred on by the mounting occurrence of bacterial infections. These infections, which are the result of microscopic organisms known as bacteria that infiltrate the body and lead to diverse diseases and symptoms, can be addressed with carbapenem-based antibiotics. These antibiotics are efficacious in treating serious or multidrug-resistant bacterial infections, including those precipitated by gram-positive and gram-negative bacteria. The Centers for Disease Control and Prevention, a government agency in the US, disclosed in a report in July 2024 that during 2023, as much as 78% of all bacterial infections were identified by CIDTs in the recorded catchment area, with 46% being diagnosed solely through CIDTs. Thus, the surge in bacterial infections enhances the expansion of the carbapenem-based antibiotics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12035&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Carbapenem-Based Antibiotics Market?
The carbapenem-based antibiotics market is experiencing significant growth due to an emphasis on product innovations, primarily from major industry players who are focusing on innovation to maintain their market position. For example, in August 2024, the UK government's National Health Service launched a ground-breaking antibiotics subscription plan in partnership with the pharmaceutical industry to fight antimicrobial resistance (AMR). The innovative scheme, announced on August 12, 2024, would let drug manufacturers receive fixed yearly payments of up to £20 million per drug, no matter how much they sell, eliminating any incentives for excessive use. The scheme, which is worth about £1.9 billion over 16 years, hopes to stimulate the discovery of new antibiotics by assuring financial feasibility for pharmaceutical firms. Following a successful trial, this initiative has been incorporated into the UK's wider approach to managing AMR, a global health issue that could result in million deaths by 2050 if not properly addressed. The NHS will focus on products that deal with critical pathogens indentified by the World Health Organization, thus demonstrating its commitment to responsible antibiotic use while promoting innovative antibiotic development.
What Are the Emerging Segments in the Carbapenem-Based Antibiotics Market?
The carbapenem-based antibiotics market covered in this report is segmented -
1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin And Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Meropenem: Meropenem Injection, Meropenem and Vaborbactam Combination, Meropenem for Pediatric Use
2) By Imipenem: Imipenem and Cilastatin Combination, Imipenem and Relebactam Combination, Imipenem Monotherapy
3) By Doripenem: Doripenem Injection, Doripenem for Complicated Infections
4) By Tebipenem: Tebipenem for Oral Administration, Tebipenem Pediatric Formulations, Tebipenem for Resistant Infections
5) By Other Types: Ertapenem, Panipenem, Faropenem, Combinations with Beta-Lactamase Inhibitors
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12035&type=smp
Who Are the Global Leaders in the Carbapenem-Based Antibiotics Market?
Major companies operating in the carbapenem-based antibiotics market include Pfizer Inc., Merck & Co. Inc., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation
Which are the Top Profitable Regional Markets for the Carbapenem-Based Antibiotics Industry?
North America was the largest region in the Carbapenem-Based Antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the carbapenem-based antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12035
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carbapenem-Based Antibiotics Market Trends That Will Shape the Next Decade: Insights from Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market here
News-ID: 4099698 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Antibiotics
Animal Feed Antibiotics Market Size and Share Forecast Outlook 2025 to 2035 : Gr …
The global animal feed antibiotics market is projected for significant expansion, with a market size of USD 2.9 billion in 2025 set to reach USD 4.4 billion by 2035, exhibiting a Compound Annual Growth Rate (CAGR) of 4.2%. This robust growth is primarily fueled by the escalating global demand for animal protein, advancements in feed additive technologies, and an increasing focus on livestock health management.
The market's trajectory is underscored by…
Emerging Trends Influencing The Growth Of The Veterinary Antibiotics Market: Col …
The Veterinary Antibiotics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Veterinary Antibiotics Market Size Expected to Be by 2034?
Recent years have seen a swift expansion in the market size of veterinary antibiotics. It is projected to skyrocket from $2.47 billion…
Ruminant Feed Antibiotics Market Customization Available
The use of animal antibiotics has emerged as a critical component of the animal welfare program, which is increasing the adoption rate of animal antibiotics. The widespread adoption of the adage "prevention is better than cure" in the field of animal welfare is increasing the vigour of animal antibiotics.
Full Access Of Report:
https://www.databridgemarketresearch.com/reports/global-ruminant-feed-antibiotics-market
Top Trending Report:
https://predatascience1234.blogspot.com/2023/08/pyruvate-kinase-pk-deficiency-market.html
https://predatascience1234.blogspot.com/2023/08/quark-and-fromage-frais-market-size.html
https://predatascience1234.blogspot.com/2023/08/returnable-pallets-packaging-market.html
Data Bridge Market Research analyses that ruminant feed antibiotics market was valued at USD 4.7 billion in…
Antibiotics Market
The antibiotics market is anticipated to expand at a CAGR of over 4% during the forecast period. The antibiotic industry is expected to show substantial growth during the forecast period. However, unnecessary use of antimicrobials is often cited as up to 50% and misuse of antimicrobials is risky to patients. Giving antibiotics when required can be lifesaving, however, giving patients antibiotics when they are not needed creates preventable harm. It…
Antibiotics Market - Battling Superbugs: Cutting-Edge Antibiotics for Resistant …
Newark, New Castle, USA: The "Antibiotics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Antibiotics Market: https://www.growthplusreports.com/report/antibiotics-market/7752
This latest report researches the industry structure, sales, revenue, price and…
Cephalosporin Antibiotics API market: Key Tactics by Players to Consolidate Pres …
"
The Cephalosporin Antibiotics API global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key…
